Blue Hat Investments

What we do

We evaluate, fund, and commercialize institutional technology.

Most research that could reach the market never does — not because the science fails, but because nobody owns the commercial work. We do. Here is exactly how.

01

Identify & Evaluate

We source technology directly from university tech-transfer offices, national labs, and research institutes, then screen it against a commercial reality test.

Our sourcing is proactive: we maintain standing dialogue with technology transfer officers, principal investigators, and research commercialization teams. Every disclosure that reaches us is scored on defensibility of the IP, technical maturity, the size and reachability of the addressable market, and the capital required to reach first revenue.

02

Fund & Structure

We provide capital and design the deal — an exclusive or field-limited license, a spinout with founding equity, or a direct investment alongside existing holders.

Structure follows the technology, not the other way around. A platform with several independent applications is usually best served by field-of-use licensing. A single product with a clear buyer often justifies a dedicated spinout entity. We negotiate terms with the institution, set the cap table, and fund the first commercialization milestones ourselves.

03

Commercialize

We run the go-to-market: manufacturing partners, certification, launch, distribution — from crowdfunding-viable consumer devices to B2B licensing programmes.

This is the part most institutional capital does not do. We build the product plan, appoint suppliers, manage regulatory and certification work where required, and run the launch. For consumer hardware, that can mean a crowdfunding-led launch that proves demand before volume tooling. For B2B, it means a licensing programme with named target licensees and a commercial pipeline.

Evaluation framework

Three decisions, made before we write a cheque.

B2B or B2C fit

The first question is who buys. A consumer product needs a story a non-expert understands, a defensible price point, and a launch channel. A B2B technology needs a named buyer inside an existing procurement category and a quantified improvement over the incumbent. Technologies that fit neither cleanly are usually not ready — or belong with a strategic acquirer rather than with us.

  • Who is the first paying customer, by name or by category?
  • Is the value proposition explainable in one sentence?
  • Does the buyer already have a budget line for this?

Licensing or spinout

Licensing is faster, cheaper, and right when the technology slots into an existing manufacturer's product line or process. A spinout is right when the technology is the product, when no incumbent has the incentive to adopt it, and when the value created justifies building a company around it. We make that call explicitly, in writing, before we commit capital.

  • Field-of-use licensing for platform technologies with several applications
  • Exclusive licensing where one adopter can carry the whole market
  • Spinout with founding equity where the product is the company

Market & crowdfunding viability

For consumer-facing hardware we use crowdfunding viability as a filter, not just a funding tactic. If a technology cannot attract pre-orders from an informed audience with a clear video and a credible price, it will not survive a retail launch either. Passing that filter validates demand before volume tooling and materially de-risks the capital.

  • Demand evidence before committing to tooling
  • Price sensitivity tested in public, not in a spreadsheet
  • A launch audience that becomes the first customer base

The pipeline

From first call to first revenue.

  1. 01

    Sourcing

    Active scouting across university tech-transfer offices, federal and national labs, and institute spin-off programmes.

  2. 02

    Evaluation

    B2B or B2C fit, license or spinout, market viability, capital intensity, and freedom to operate — assessed in a single structured review.

  3. 03

    Funding & Deal Structuring

    Term negotiation with the institution, capital commitment, and the legal vehicle: license agreement, NewCo, or direct investment.

  4. 04

    Commercialization

    Product definition, manufacturing and supply, certification, pricing, and the launch route — including crowdfunding where it fits.

  5. 05

    Ongoing Support

    Operating support, follow-on capital, licensee management, and reporting back to the originating institution.

Have something in the pipeline?

Submit a technology